Clinical Trials Insight: 700015560
Latest Information Update: 27 Oct 2006
Price :
$35 *
At a glance
- Drugs KD 3010 (Primary)
- Indications Obesity
- Focus Adverse reactions
- Sponsors Kalypsys
- 27 Oct 2006 The expected completion date for this trial is now 31 Oct 2006.
- 03 Oct 2006 New trial record.